By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Entia Biosciences, Inc.

Entia Biosciences, Inc. (ERGO)

OTC Currency in USD
$0.00
$0.00
+100.00%
Last Update: 29 Aug 2025, 00:00
$6.73K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

ERGO Stock Price Chart

Explore Entia Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze ERGO price movements and trends.

ERGO Company Profile

Discover essential business fundamentals and corporate details for Entia Biosciences, Inc. (ERGO) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

18 Jan 2008

Employees

6.00

CEO

Timothy A. Timmins

Description

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.

ERGO Financial Timeline

Browse a chronological timeline of Entia Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

ERGO Stock Performance

Access detailed ERGO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run